Terms: = Head and neck cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
1509 results:
1. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract] [Full Text] [Related]
2. The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma.
Filippini DM; Le Tourneau C
Curr Opin Oncol; 2024 May; 36(3):147-154. PubMed ID: 38573203
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer.
Zhao Y; Wucherpfennig KW
Curr Opin Oncol; 2024 May; 36(3):136-142. PubMed ID: 38573202
[TBL] [Abstract] [Full Text] [Related]
4. head and neck cancer patients treated with concomitant chemoradiotherapy involving the oral cavity and oropharynx: is another choice possible than prophylactic gastrostomy?
Senesse P; Briant J; Boisselier P; Bensadoun RJ; Vinches M; Faravel K
Curr Opin Oncol; 2024 May; 36(3):128-135. PubMed ID: 38573201
[TBL] [Abstract] [Full Text] [Related]
5. head and neck Mucosal Melanoma: Where Are We Now?
Hanba C; Hanna E
Curr Oncol Rep; 2024 Apr; 26(4):421-425. PubMed ID: 38512416
[TBL] [Abstract] [Full Text] [Related]
6. Advances in testing for human papillomavirus -mediated head and neck cancer.
Mehanna H; Alemany L; von Buchwald C
Curr Opin Oncol; 2024 May; 36(3):143-146. PubMed ID: 38506408
[TBL] [Abstract] [Full Text] [Related]
7. Central nervous system adverse events of immune checkpoint inhibitors.
Farina A; Villagrán-García M; Vogrig A; Joubert B
Curr Opin Neurol; 2024 Jun; 37(3):345-352. PubMed ID: 38483130
[TBL] [Abstract] [Full Text] [Related]
8. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
[TBL] [Abstract] [Full Text] [Related]
9. Managing lymphoedema following treatment for head and neck cancer: is complete decongestive therapy an effective intervention to improve dysphagia outcomes?
Smith A
Curr Opin Otolaryngol Head Neck Surg; 2024 Jun; 32(3):178-185. PubMed ID: 38393685
[TBL] [Abstract] [Full Text] [Related]
10. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors.
Hoch CC; Knoedler L; Knoedler S; Bashiri Dezfouli A; Schmidl B; Trill A; Douglas JE; Adappa ND; Stögbauer F; Wollenberg B
Curr Oncol Rep; 2024 Mar; 26(3):272-291. PubMed ID: 38376625
[TBL] [Abstract] [Full Text] [Related]
11. Anlotinib suppressed tumor cell proliferation and migration in hypopharyngeal carcinoma.
Song H; Song Q; Zhao X; Yang Y; Mou Y; Li Y; Song X
Braz J Otorhinolaryngol; 2024; 90(2):101397. PubMed ID: 38330738
[TBL] [Abstract] [Full Text] [Related]
12. The added value of radiomics in determining patient responsiveness to laryngeal preservation strategies.
Ravanelli M; Rondi P; Di Meo N; Farina D
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):134-137. PubMed ID: 38259164
[TBL] [Abstract] [Full Text] [Related]
13. Quality of life following treatment with intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.
Cossyleon R; Robinson K; Delfino K; Robbins KT; Rao K
Support Care Cancer; 2024 Jan; 32(2):93. PubMed ID: 38193937
[TBL] [Abstract] [Full Text] [Related]
14. head and neck nonmelanoma skin cancers: surgical management and debated issues.
Rampinelli V; Pinacoli A; Piazza C
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):62-70. PubMed ID: 38193646
[TBL] [Abstract] [Full Text] [Related]
15. Compartmental surgery for T4b oral squamous cell carcinoma involving the masticatory space.
Mattavelli D; Montenegro C; Piazza C
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):55-61. PubMed ID: 38193497
[TBL] [Abstract] [Full Text] [Related]
16. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
[TBL] [Abstract] [Full Text] [Related]
17. Radical resection of mandibular ameloblastoma and functional reconstruction with a fibula free flap. Report of two cases and review of the literature.
Roman RC; Faur CI; Boțan E; Bidiga Ș; Moldovan MA
Ann Ital Chir; 2023 Dec; 12():. PubMed ID: 38140922
[TBL] [Abstract] [Full Text] [Related]
18. Surgical treatment and prognosis of recurrent and radiotherapy insensitive nasopharyngeal carcinoma.
Zhao Y; Fang J; Zhong Q; Zhang J; Chen J; Hou L; Wang R
Braz J Otorhinolaryngol; 2024; 90(2):101366. PubMed ID: 38134866
[TBL] [Abstract] [Full Text] [Related]
19. Radiation oncology for the rhinologist.
Levyn H; Yang F; Lee NY
Curr Opin Otolaryngol Head Neck Surg; 2024 Feb; 32(1):5-13. PubMed ID: 38116957
[TBL] [Abstract] [Full Text] [Related]
20. Oncology for the rhinologist.
Tam K; Dunn LA; Cohen MA
Curr Opin Otolaryngol Head Neck Surg; 2024 Feb; 32(1):14-19. PubMed ID: 38116847
[TBL] [Abstract] [Full Text] [Related]
[Next]
